Browsing Tag
Lazard
11 posts
Beazley (LSE: BEZ) edges up 0.04% on Friday with Zurich scheme on glide path to court sanction and H2 completion
Beazley shareholders voted 99.9% in favour. Zurich keeps buying at 1,280p. The court hearing is next. The 2.3% arbitrage spread is the last word on this deal.
Lincoln International IPO: Why the $421m listing could test Wall Street’s appetite for boutique advisory firms
Advisory fees are recovering, but IPO investors want durability. Lincoln International’s LCLN listing tests Wall Street’s boutique bank appetite.
SoundHound AI bets on enterprise AI consolidation with LivePerson deal as SOUN trades near 52-week lows
SoundHound AI to acquire LivePerson in an all-stock deal targeting a $500M revenue opportunity. What the $250M enterprise value transaction means for SOUN investors and enterprise AI. Read more.
Rogo expands financial AI platform with Offset acquisition to automate spreadsheet-driven finance work
Rogo acquires Offset to bring AI agents directly into financial workflows used by banks and private equity firms. Discover what this shift could mean for finance.
Lilly (NYSE: LLY) to acquire Orna Therapeutics for $2.4bn to expand in vivo CAR-T strategy
Eli Lilly and Company (LLY) to acquire Orna Therapeutics for up to $2.4B. Explore how in vivo CAR-T and circular RNA may transform autoimmune therapy.
Can NCC Group thrive without Escode? Inside the £275m pivot to Cyber
NCC to sell Escode to TDR Capital for £275M to focus on cybersecurity. Find out what this means for strategy, margins, and investor returns.
KKR and Stonepeak launch £1.6bn bid to take Assura private via scheme of arrangement
Find out how KKR and Stonepeak plan to reshape UK healthcare infrastructure through a £1.6B buyout of FTSE 250 REIT Assura plc.
ABC technologies announces £1.8bn acquisition of TI Fluid Systems
ABC Technologies has announced a landmark transaction: the acquisition of TI Fluid Systems for £1.83 billion. This transformative…
PepsiCo announces $1.2bn acquisition of Siete Foods to expand multicultural portfolio
PepsiCo, Inc., one of the world’s largest food and beverage companies, has announced a definitive agreement to acquire…
OcuMension secures Alcon eye drop rights with 16.7% stake, marking major strategic shift
OcuMension Therapeutics has struck a landmark deal with Alcon Inc., acquiring commercialization rights for a portfolio of eye…